Cargando…
Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report
BACKGROUND: Thymic epithelial carcinomas are rare and have a poor prognosis. Treatment of thymic epithelial carcinoma is multimodal and includes surgery, post-operative radiation therapy, adjuvant and neoadjuvant chemotherapy, or exclusive chemotherapy based on disease resectability. However, there...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896660/ https://www.ncbi.nlm.nih.gov/pubmed/33644178 http://dx.doi.org/10.12998/wjcc.v9.i5.1139 |